Income Taxes (Schedule of Deferred Tax Assets and Liabilities) (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Income Tax Disclosure [Abstract]
Net operating loss carryforwards	$ 41,333	$ 29,999
Research and development credits	7,975	5,026
Stock-based compensation	1,062	1,132
Operating lease liabilities	9,184	7,466
Capitalized research & experimental expenditures	24,975	19,036
Deferred revenue	3,234	3,768
Other	785	920
Total gross deferred tax assets	88,548	67,347
Less: valuation allowance	(84,810)	(59,956)
Total deferred tax assets	3,738	7,391
Operating lease right-of-use assets	(3,738)	(7,391)
Total deferred tax liabilities	$ (3,738)	$ (7,391)